创五年最佳！九成FOF业绩飘红

Core Viewpoint - Publicly offered Fund of Funds (FOF) has achieved its best performance in five years, primarily driven by heavy investments in equity funds, particularly in the pharmaceutical and technology sectors [1][2][3]. Group 1: Performance Metrics - As of August 17, 2023, over 95% of FOF products have reported positive returns for the year, with the best-performing FOF achieving a return of 34.28% [2]. - The annual highest returns for public FOFs from 2021 to 2024 were 14.57%, 0.29%, 3.69%, and 17.14%, indicating a significant recovery in 2024 [2]. - The total number of FOFs in the market reached 518, with a total management scale of 156.44 billion yuan, reflecting a quarter-on-quarter increase of 9.45% [3]. Group 2: Investment Strategy Shift - FOFs have shifted their focus from conservative bond funds to more aggressive equity funds, with top-performing FOFs primarily holding stock-based investments [4][5]. - The top three FOFs by performance are heavily weighted in equity funds, with the leading FOF, Guotai Youxuan Lihang, investing predominantly in stock-based funds [4]. - The strategy of investing in high-yield funds, particularly those focused on technology and Hong Kong stocks, has become crucial for FOFs to maintain their client base and product viability [5][8]. Group 3: Market Trends and Client Retention - The current market trend shows a strong demand for FOFs that focus on high-elasticity equity funds, especially in technology and healthcare sectors, as clients are less likely to invest in FOFs heavily weighted in bond funds [8]. - The shift towards equity funds has not only helped FOFs escape a four-year performance slump but has also enhanced their ability to retain clients by demonstrating profitability [8][7].